Melanoma cells with acquired resistance to dabrafenib display changes in miRNA expression pattern and respond to this drug with an increase of invasiveness, which is abrogated by inhibition of NF-κB or the PI3K/mTOR signalling pathway

Eitemau Tebyg

• miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A
  gan: Simona Caporali, et al.
  Cyhoeddwyd: (2019-06-01)
• miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A
  gan: Caporali, Simona, et al.
  Cyhoeddwyd: (2019)
• Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib
  gan: Caporali, Simona, et al.
  Cyhoeddwyd: (2017)
• Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1
  gan: Ruffini, Federica, et al.
  Cyhoeddwyd: (2017)
• Neuropilin-1 expressing melanoma cells as a model to study the aggressiveness of metastatic melanoma
  gan: Ruffini, Federica, et al.
  Cyhoeddwyd: (2015)